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Remodeling of Airway Walls in Fatal
Asthmatics Decreases Lymphatic
Distribution; Beyond Thickening of
Airway Smooth Muscle Layers
Masahito Ebina1
ABSTRACT
Background: We previously reported the phenotypic distribution patterns of airway smooth muscles in fatal
asthmatics; Type I asthmatics with smooth muscle bundle thickening only in large airways and Type II in whole
airways. We hypothesized that increased smooth muscle bundles in the airway walls would disrupt airway lym-
phatics to impair airway clearance in these fatal asthmatics.
Methods: The autopsy lungs of seven fatal asthmatics (three Type I, four Type II asthmatics) and five controls
were examined by immunohistochemistry to reveal the lymphatics distributed in the airway walls. The total area
of lymphatics around each cross-sectioned airway was measured and its airway radius was calculated using an
image analyzer system. Finally, the distribution areas of lymphatics in the same level of airways of bronchial
trees were compared among Type I, Type II asthmatics and controls.
Results: The total area of airway lymphatics in each lung was found to be positively correlated with the airway
radius (R). The distribution areas of lymphatics in larger airways (1.5 < R < 2.0 mm) of both types of asthmatics
were significantly decreased than controls, and Type I asthmatics contained much less lymphatics than Type II
asthmatics in these airways. The lymphatics around smaller airways (0.5 < R < 1.0 mm) were also reduced in
both phenotypes of asthmatics without statistic difference between them. The airway lymphatics of these fatal
asthmatics were observed to be interrupted by thickened muscle bundle layers, and by fibrotic tissues devel-
oped around these airways as well.
Conclusions: These results indicate that distribution of lymphatics were decreased in the airway walls of fatal
asthmatics which contained muscle bundles and fibro-connective tissues both of which were augmented in
these airway walls to disrupt lymphatics, impair airway clearance and accelerate mucosal edema which would
cause refractory status of these patients.
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INTRODUCTION
Despite the emergence of novel therapeutic strate-
gies for patients with bronchial asthma, there remain
severe asthmatics who suffer from continuous severe
asthmatic attacks and chronic dyspnea. To under-
stand the pathogenesis of refractory conditions of
these patients, there is a need to analyze the patho-
genesis of the airway remodeling in fatal asthmatics.
We previously reported morphometric analysis of
thickened airway smooth muscle layers of patients
who died of asthma in comparison with normal con-
trol lungs,1 differentiated two distribution patterns of
thickening in the airway smooth muscle layers2 and
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Table 1 The lungs of patients examined; their clinical background and pathologic findings
Pathologic findingsClinical background
Peri-airway fibrosisMuscular thickeningDuration
of asthmaGenderAge
Patient
No. Smal airwaysLarge airwaysSmal airwaysLarge airways
Type I asthmatics
＋＋＋＋＋ /－＋＋＋10 yrF58 yr1
＋＋＋＋＋－＋＋＋14 yrF63 yr2
＋＋＋＋＋ /－＋＋＋11 yrM71 yr3
Type I asthmatics
＋＋＋＋＋＋＋＋ 7 yrM21 yr4
＋＋＋＋＋＋＋＋ 5 yrM61 yr5
＋＋＋＋＋＋＋＋ 6 yrM68 yr6
＋＋＋＋＋＋＋＋＋13 yrF64 yr7
defined the muscular hypertrophy andor hyperpla-
sia which contributed to the muscular thickening in
these phenotypes of fatal asthmatics.3 These pheno-
types of fatal asthmatics consist of Type I asthmatics
whose muscle layers were increased only in the
larger airways, and Type II, who exhibited thickened
muscular layers in the entire airways in bronchial
trees, from the central to peripheral regions.2 These
increased muscle layers surrounding the airways are
thought to reflect hypersensitive airway constrictions
in these patients, which would contribute to airway
narrowing by constricting the airways more power-
fully and more frequently, making the airway walls
become rigid with the excessive airway folding, and
causing inflammation by cytokine-secretion.4 The im-
portant role of muscular thickening of the airways in
severe asthmatics may be in the process of being re-
recognized because of recent reports of successful
asthma control by bronchial thermoplasy targeting
airway smooth muscles,5 even though the mecha-
nism underlying the therapeutic effect in asthma has
not been fully established yet.
Mucosal edema is also a notorious factor for accel-
erating severe airway narrowing in bronchial asthma
as well as sub-epithelial fibrosis, deposition of matrix
around the airways, and mucus plugging with in-
creased tall columnar airway-epithelial cells. Recent
studies using mouse models of chronic respiratory
tract infection showed that blood vessel remodeling
and lymphangiogenesis were both robust in infected
airways, and that lack of lymphatic growth exagger-
ated mucosal edema. These findings suggest that
when lymphangiogenesis is impaired airway inflam-
mation may lead to bronchial edema and exaggerated
airflow obstruction.6 As is broadly acknowledged, the
lungs possess a highly developed network of lym-
phatics, consisting of a “superficial” or pleural plexus
and a “deep” or peribronchovascular plexus, located
in the connective tissue surrounding the airways, pul-
monary arteries, and veins.7 Although the disruption
of lymphatics would possibly be an important patho-
genesis of mucosal edema in bronchial asthma, no in-
formation has been reported on the remodeling of
lymphatics in the airway walls of these patients. In
this context, the morphological changes in the air-
ways of the fatal asthmatics analyzed in our previous
studies1-3 were re-examined and the remodeling of
lymphatics in these airways was evaluated.
METHODS
THE LUNG TISSUES EXAMINED
The lung tissues examined in this study were ob-
tained from the postmortem lungs of seven fatal asth-
matics who died of asthma, three Type 1 asthmatics
whose muscle layers were increased only in the
larger airways and four Type 2 asthmatics who exhib-
ited thickened muscular layers in the entire airways
in bronchial trees, both of these phenotypes of fatal
asthmatics were distinguished in our previous stud-
ies.2 The clinical backgrounds of these seven fatal
asthmatics were shown in Table 1. These lungs were
selected from the samples used in the previous stud-
ies2,3 because of the reliable immunoreactivity re-
quired for this current study. Five autopsy lungs with-
out chronic lung diseases or cancer were also exam-
ined. All of these lung tissues were obtained at To-
hoku University Hospital and the approval of the eth-
ics committee of Tohoku University was obtained to
use these clinical samples.
IMMUNOHISTOCHEMISTRY
For our pilot study on lymphatic endothelial cells, we
employed anti-human podoplanin monoclonal anti-
body (AngioBio), D2-40 (Nichirei), a rabbit polyclo-
nal antibody against human LYVE-1 (Research Diag-
nostic), and an antihuman VEGFR-3 goat antibody (R
&D). We chose podoplanin for further study for its
specific and intense staining. The other monoclonal
antibodies used in this study were the antibodies
against human CD34 (Nichirei) and von Willebrand
factor (vWF) (Nichirei). A rabbit polyclonal antibody
against human VEGF-C (IBL) and a goat polyclonal
antibody against human VEGF-D (R&D) were also
used. The antigen-antibody complex was visualized
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Fig. 1 Lymphatics in the airway wals in control lungs. A&B: In the bronchial wals 
of control lungs, lymphatic capilaries (immunostained in red) are distributed in the 
sub-mucosal tissues where airway smooth muscles distribute thinly and in the bot-
tom of airway epithelial cels. The boxed area by broken lines in A is enlarged in B 
(bars＝100 μm, back stained by E―G). C&D: Double immunostaining of lymphatic 
(in red, marked by＊) and vWF-positive capilary endothelial cels (in brown) reveals 
dense distribution of both capilaries in the wals of a smal airway of a control, the ra-
dius of which is approximately 0.15 mm (bars＝100 μm, back stained by E―G). E: 
The data of total areas of lymphatics around each airway of five control lungs, 52 air-
ways in total, were pooled.There is a significant corelation between them with a co-
eficient of r＝0.952 (p＜0.001).
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Fig. 2 Lymphatics in the airway wals in Type 1 asthmatics (bars＝100 μm except B). A&B: A smal air-
way of Type I asthmatics (Case 1) is surounded by thick fibrotic tissues with atrophic smal muscle bun-
dles (A, EM staining) with fibrotic changes in part (B, E―G staining, bar＝10 μm). C&D: A smal airway 
of Type I asthmatics (Case 2) surounded by thick fibrotic tissues where no airway smooth muscles are 
observed (C, E―G staining). In the consecutive section (D), double immunostaining of lymphatic (in red, 
marked by＊) and vWF-positive capilary endothelial cels (in brown, indicated by arows) shows scarce 
distribution of lymphatics, though vWF＋ blood vessels penetrated the fibrotic tissues into epithelial cels 
(indicated by a white arow). E&F: A smal airway of Type I asthmatics (Case 3) were also surounded by 
thick fibrotic tissues without muscle layers (E, E―G stain) and few lymphatics (in red) were distributed in 
the airway wals (F).
A B
C D
FE
by Vector Red (Vector Laboratories) andor diamino-
benzidine (DAB), and counterstained by elastica-
Goldner (E-G) stain, modification elastica-Mason
stain.1
MORPHOMETRIC EVALUATION
The total distribution areas of the lymphatics in air-
way walls and the perimeter of each airway were
measured by a digital image analyzer (Lumina Vision,
Mitani Corporation, Fukui) at the final magnification
Reduced Lymphatics in Fatal Asthmatics
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Fig. 3 The distribution of airway lymphatics in Type I 
asthmatics. A: The data of total areas of lymphatics around 
each airway of Type I asthmatics (Case 1), 19 airways in to
tal, were ploted (r＝0.752, p＜0.001). In comparison with 
the regression line of 5 control lungs, revealed as a broken li
ne, the lymphatic distribution in the airway wals of this case 
is significantly decreased. B: The pooled data of the lym
phatics around each airway of 3 cases of Type I asthmatics, 
44 airways in total, were ploted. Although the data are dis
persed, there is a positive corelation between them (r＝
0.656, p＜ 0.001). Note again the lymphatic distribution 
around airways of these patients is decreased in compari
son with the regression line in controls (a broken line).
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of 40,000. The radius of each airway was calculated
from its perimeter.
STATISTICAL ANALYSIS
For analysis of two unpaired samples, the nonpara-
metric Mann-Whitney U test was used (Stat View
ver.5; Abacus Concepts Inc., Berkley, California). Sig-
nificant difference was defined as p < 0.05 and no sig-
nificant difference was determined by Student T test.
All values were represented as the means ± SEM.
RESULTS
AIRWAY LYMPHATICS IN CONTROLS
We examined first to show the distribution of lym-
phatic capillary endothelial cells in airway walls of
control lungs (Fig. 1). From large to small airways,
lymphatics are diffusely distributed in the airway
walls of these control lungs. In larger airways, the
lymphatics are dilated and observed clearly in the
submucosal tissues and also in the bottom of airway
epithelial layers (Figs. 1A, B). Even in the small air-
ways, they are distributed close to airway lumen
(Figs. 1C, D). The regression line (y = −0.05 + 0.139
x) was obtained from the pooled data of 52 airways
and there was found to be a close positive correlation
between the total areas of airway lymphatics and the
radius of each airway in these control lungs (r =
0.952, p < 0.001) (Fig. 1E).
AIRWAY LYMPHATICS IN TYPE I ASTHMATICS
Type I asthmatics were revealed to have thickening
of airway smooth muscles chiefly in larger airways by
our previous study.1 The autopsy lungs of three pa-
tients of Type I asthmatics (Table 1) were examined.
Although the airway smooth muscle bundles in the
peripheral airways were not thick, the peri-airway fi-
brosis was found to be increased in these lungs (Fig.
2). In the lung tissues of Case 1, muscle bundles
were observe to be atrophic in the thick fibrotic tis-
sues and changed in part into fibrosis (Figs. 2A, B).
The airway walls in the lung tissues of Case 2 were
completely changed to fibrosis where only small
blood vessels, but not lymphatics, penetrated into air-
way epithelial layers (Figs. 2C, D). The small airways
of Case 3 of Type I asthmatics were also changed to
fibrosis, and few lymphatics were recognized sur-
rounding the airways (Figs. 2E, F). Figure 3A shows
relation between lymphatic areas and each airway ra-
dius in Case 1 of Type I asthmatics. The airway lym-
phatics are remarkably decreased in Type I asthmat-
ics in comparison with controls. This tendency was
also confirmed by the regression line (y = −0.007 +
0.023x) from the pooled data of three cases of Type I
asthmatics (Fig. 3B).
AIRWAY LYMPHATICS IN TYPE II ASTHMATICS
In the large bronchi of Type II asthmatics (Table 1),
where the airway smooth muscle layers are thick
(Fig. 4A), the distribution of lymphatics in the airway
walls are attenuated in comparison with control lungs
(Figs. 4B―D). Lymphatics with penetrating basement
membranes into epithelial layers are rarely observed
and were interrupted by thick muscle layers sur-
rounding the constricted airways (Figs. 4B―D). In
contrast, the blood capillaries were densely distrib-
uted even in the protruded fold of the airway walls
with thick connective tissues and elastic fibers and
these blood capillaries extended over sub-epithelial fi-
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Fig. 4 The distribution of airway lymphatics in Type I asthmatics. A―B: The airway wals in 
controls stained by EM are folowed by a serial section immunochemicaly stained for lymphat-
ics (in red) in B. C―F: The airway wals in bronchi (C―D) and bronchioles (E―F) in double im-
munohistochemistry stain for podoplanin with lymphatic capilary endothelial cels appeared in 
red and blood vessels with vWF-positive (in brown) endothelial cels. Note the root of lymphatics 
toward airway lumen are blocked and changed by thick muscular mass (B―D). G―H: Double im-
munohistochemistry stain for lymphatic growth factors VEGF-C (G) or VEGF-D (H) in brown and 
podoplanin-positive lymphatic capilary endothelial cels in red (ASM, airway smooth muscles; 
AL, airway lumen; BG, bronchial glands).
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Fig. 5 The distribution of airway lymphatics in Type I 
asthmatics. A: The data of total areas of lymphatics around 
each airway of Type I asthmatics (Case 4), 8 airways in to
tal, were ploted (r＝0.928, p＜0.001). In comparison with 
the regression line of 5 control lungs, revealed as a broken li
ne, the lymphatic distribution in the airway wals of this case 
is decreased. B: The pooled data of the lymphatics around 
each airway of 4 cases of Type I asthmatics, 42 airways in 
total, were ploted. Although the data are dispersed among 
the cases, there is again a positive corelation between them 
(r＝0.768, p＜0.001). The lymphatic distribution around air
ways of these patients is decreased in comparison with the 
regression line in controls (a broken line).
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brosis and were distributed within the airway epithe-
lial layers (Figs. 4D, E). This different distribution
patterns between lymphatic and blood capillaries are
also observed in the small airways of Type II asthmat-
ics, whereas only Type II asthmatics contained thick
muscle layers (Figs. 4E, F). The airway epithelial
cells of these fatal asthmatics, from both the large to
the small airways, were intensely immunoreactive for
the lymphatic growth factors VEGF-C and VEGF-D
(Figs. 4G, H). However, the extension of new lym-
phatics into these airway epithelial layers seemed to
be interrupted by thick muscle layers and connective
tissues, including sub-epithelial fibrosis (Figs. 4G, H).
Relation between lymphatic areas and each airway
radius in Case 4 of Type II asthmatics shows airway
lymphatics were less distributed than controls but
more than Type I asthmatics (Fig. 5A), as confirmed
by the regression line (y = −0.019 + 0.058x) of the
pooled data of four cases of Type II asthmatics
(Fig. 5B).
STATISTIC ANALYSIS OF LYMPHATIC DISTRI-
BUTIONS IN THE AIRWAYWALLS
Figure 6A shows all the pooled data of lymphatic ar-
eas in the airway walls of Type I (44 airways in 3
cases), Type II asthmatics (42 airways in 4 cases),
and controls (52 airways in 5 cases) plotted together.
The mean value of lymphatic areas of each case in
smaller airways (0.5 mm < R < 1 mm) and in larger
airways (1.5 mm < R < 2.0 mm) were calculated (Fig.
6B). The airway lymphatics in both Type I (0.008 ±
0.004 mm2 in smaller airways, 0.028 ± 0.007 mm2 in
larger ways) and Type II asthmatics (0.016 ± 0.005
mm2 in smaller airways, 0.080 ± 0.004 mm2 in larger
ways) were decreased in the whole airways, in com-
parison with controls (0.042 ± 0.004 mm2 in smaller
airways, 0.191 ± 0.017 mm2 in larger ways), and espe-
cially Type 1 asthmatics decreased lymphatics more
than Type II asthmatics in larger airways.
DISCUSSION
Although airway hyper-reactivity is one of the most
characteristic features of bronchial asthma, irrevers-
ible and chronic constrictions of the airway are
thought to advance mild asthma to refractory status.
In this sense, the postmortem lungs of fatal asthmat-
ics have provided important information on airway re-
modeling in these patients, much of which is different
from the pathological features observed in the biop-
sied materials of ordinary, mild asthmatics. Because
of the diversity in prognosis among the phenotypes of
these asthmatics, it is important to determine the
pathogenesis which differentiates these phenotypes
in a range from mild to fatal, and invent new strate-
gies for early diagnosis and subsequently successful
treatment of refractory asthmatics. We should iden-
tify the genetic predisposition and susceptibility of
these patients, which are now profoundly believed to
underlie the pathogenesis of bronchial asthma, as in
various other diseases.
Among the structural changes reported in the air-
ways of asthmatics are included epithelial injury, gob-
let cell hyperplasia, enlarged submucosal mucus
glands, angiogenesis, increased deposition of extra-
cellular matrix in the airway wall, and increased air-
way smooth muscle layer. The importance of airway
smooth muscle involvement should be re-evaluated
because of the recent report on successful asthma
control by bronchial thermoplasy targeting the air-
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Fig. 6 Comparison of lymphatic distributions in the airway wals among 
Type I, Type I asthmatics, and controls. A: Al of the pooled data of lym
phatic areas in the airway wals of Type I (3 cases), Type I asthmatics (4 
cases), and controls (5 cases) were ploted together. The regression lines 
of these three groups were also compared. B: For statistic analysis, the 
mean value of lymphatic areas of each case in smaler airways (0.5 mm ＜
R＜ 1 mm) and in larger airways (1 mm ＜R＜ 1.5 mm) were calculated 
and the means ± SEM of each group in these rages of airways were 
ploted. The airway lymphatics in both Type I and Type I asthmatics were 
decreased in the whole airways, and especialy Type 1 asthmatics de
creased lymphatics more than Type I asthmatics in larger airways.
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way smooth muscle,5 although the mechanism under-
lying this effect in asthma as not been fully estab-
lished yet.
Our results in this study indicate the reduced dis-
tribution of lymphatics in the airway walls of fatal
asthmatics where the thick muscle layer andor fibro-
connective tissue develop. In contrast, the vascular
densities are augmented in these airway walls, even
within the epithelial layers. Considering that the mu-
cosal edema induces airway narrowed, the reduced
distribution in lymphatics in the airway walls of fatal
asthmatics are thought to cause impairment of lym-
Reduced Lymphatics in Fatal Asthmatics
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Fig. 7 Scheme of hypothetic roles of lymphatic disruption in the patho
genesis of refractory asthma
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phatic drainage of the airway epithelial layers in these
lungs. The increased blood capillaries in these le-
sions may be required for maintaining the airway re-
modeling, which is composed of hyperplasia of goblet
and airway epithelial cells, along with muscular mass,
but these thick airway walls with sub-epithelial fibro-
sis prevent the development of lymphatic capillaries
by blocking the permeation of lymphatic growth fac-
tors, VEGF-C andor D, which are produced by air-
way epithelial cells.6 The hypothesis of reduced lym-
phatics in the airway walls of fatal asthmatics and the
influence on the pathogenesis of this refractory dis-
ease should be clarified in future study.
The hypothetical roles of disruption of airway lym-
phatics in the pathogenesis of refractory asthma are
shown schematically in Figure 7. The airway epithe-
lial injury and apoptosis induced by chronic inflam-
mation with and without allergic reaction induce type
2 cytokine-dominant inflammation, which induces hy-
pertrophy and hyperplasia of airway smooth muscle
by recurrent contraction and the activity of growth
factors. IL-13, one of the important cytokines for air-
way remodeling, differentiates ciliated epithelial cells
to goblet cells,8 which comprise the mucus plugs in
the airways.9 TGF-β is produced as an anti-
inflammatory factor against excessive inflammation in
the tissues,10 which differentiates fibroblasts into my-
ofibroblasts which produce matrix protein around the
airways and thus generate sub-epithelial fibrosis.
These thick airway walls composed of muscular bun-
dle layer and fibro-connective tissues interrupt the ex-
tension of lymphangiogenesis to the epithelial layers,
where extensive angiogenesis takes place to support
the growth of goblet cell hyperplasia and mucus se-
cretion. The unbalanced distribution of lymphatics
and blood capillaries, with reduced lymphatics and in-
creased blood capillaries, prolongs the mucosal and
peri-airway edema which accelerates airway obstruc-
tion and ultimately leads to fatality in severe asthmat-
ics.
In conclusion, the impairment of airway lymphatics
in the fatal asthmatics discovered first in this study
should be a novel target of therapeutic strategies
against this refractory airway disease.
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